1082 related articles for article (PubMed ID: 11400797)
1. Preventation of thalassemia in Australia.
Hendy J
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():94-6. PubMed ID: 11400797
[TBL] [Abstract][Full Text] [Related]
2. Detection of alpha-thalassemia in beta-thalassemia carriers and prevention of Hb Bart's hydrops fetalis through prenatal screening.
Li D; Liao C; Li J; Xie X; Huang Y; Zhong H
Haematologica; 2006 May; 91(5):649-51. PubMed ID: 16627247
[TBL] [Abstract][Full Text] [Related]
3. Prenatal diagnosis of hemoglobinopathies in Ontario, Canada.
Basran RK; Patterson M; Walker L; Nakamura LM; Eng B; Chui DH; Waye JS
Ann N Y Acad Sci; 2005; 1054():507-10. PubMed ID: 16339708
[TBL] [Abstract][Full Text] [Related]
4. Distribution of thalassemias and associated hemoglobinopathies identified by prenatal diagnosis in Taiwan.
Peng CT; Liu SC; Peng YC; Lin TH; Wang SJ; Le CY; Shih MC; Tien N; Lu JJ; Lin CY
Blood Cells Mol Dis; 2013 Oct; 51(3):138-41. PubMed ID: 23689197
[TBL] [Abstract][Full Text] [Related]
5. Analysis of fetal blood using capillary electrophoresis system: a simple method for prenatal diagnosis of severe thalassemia diseases.
Srivorakun H; Fucharoen G; Sae-Ung N; Sanchaisuriya K; Ratanasiri T; Fucharoen S
Eur J Haematol; 2009 Jul; 83(1):57-65. PubMed ID: 19226360
[TBL] [Abstract][Full Text] [Related]
6. Carrier screening and prenatal diagnosis of hemoglobinopathies. A study of indigenous and immigrant couples in northern Greece, over the last 5 years.
Theodoridou S; Alemayehou M; Prappas N; Karakasidou O; Aletra V; Plata E; Tsaftaridis P; Karababa P; Boussiou M; Sinopoulou K; Hatzi A; Voskaridou E; Loutradi A; Manitsa A
Hemoglobin; 2008; 32(5):434-9. PubMed ID: 18932067
[TBL] [Abstract][Full Text] [Related]
7. Carrier screening for alpha- and beta-thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal hospital.
Liao C; Mo QH; Li J; Li LY; Huang YN; Hua L; Li QM; Zhang JZ; Feng Q; Zeng R; Zhong HZ; Jia SQ; Cui YY; Xu XM
Prenat Diagn; 2005 Feb; 25(2):163-71. PubMed ID: 15712323
[TBL] [Abstract][Full Text] [Related]
8. Prenatal diagnosis of Hb Bart's hydrops fetalis caused by a genetic compound heterozygosity for two different alpha-thalassemia determinants.
Siriratmanawong N; Pinmuang-Ngam C; Fucharoen G; Fucharoen S
Fetal Diagn Ther; 2007; 22(4):264-8. PubMed ID: 17369692
[TBL] [Abstract][Full Text] [Related]
9. Prenatal diagnosis of thalassemia and hemoglobinopathies in Thailand: experience from 100 pregnancies.
Fucharoen S; Winichagoon P; Thonglairoam V; Siriboon W; Siritanaratkul N; Kanokpongsakdi S; Vantanasiri C
Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):16-29. PubMed ID: 1948258
[TBL] [Abstract][Full Text] [Related]
10. Carrier screening for thalassemia and hemoglobinopathies in Canada.
Langlois S; Ford JC; Chitayat D; ;
J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of hemoglobinopathies in Hacettepe University, Turkey.
Beksac MS; Gumruk F; Gurgey A; Cakar N; Mumusoglu S; Ozyuncu O; Altay C
Pediatr Hematol Oncol; 2011 Feb; 28(1):51-5. PubMed ID: 20863160
[TBL] [Abstract][Full Text] [Related]
12. Accurate prenatal diagnosis of Hb Bart's hydrops fetalis in daily practice with a double-check PCR system.
Karnpean R; Fucharoen G; Fucharoen S; Sae-ung N; Sanchaisuriya K; Ratanasiri T
Acta Haematol; 2009; 121(4):227-33. PubMed ID: 19546525
[TBL] [Abstract][Full Text] [Related]
13. Prevention of hemoglobinopathies in Egypt.
El-Beshlawy A; Youssry I
Hemoglobin; 2009; 33 Suppl 1():S14-20. PubMed ID: 20001619
[TBL] [Abstract][Full Text] [Related]
14. Interaction of hemoglobin E with other abnormal hemoglobins.
Edison ES; Shaji RV; Chandy M; Srivastava A
Acta Haematol; 2011; 126(4):246-8. PubMed ID: 21986214
[No Abstract] [Full Text] [Related]
15. Prevention of beta-thalassemia major and Hb Bart's hydrops fetalis syndrome.
Beris P; Darbellay R; Extermann P
Semin Hematol; 1995 Oct; 32(4):244-61. PubMed ID: 8560282
[No Abstract] [Full Text] [Related]
16. Newborn screening for sickle cell and other hemoglobinopathies: a Canadian pilot study.
Yorke D; Mitchell J; Clow C; Nuguid E; Cadogan R; Sinclair D; Luscombe S; Rozen R; Meredith P; Esseltine D
Clin Invest Med; 1992 Aug; 15(4):376-83. PubMed ID: 1516295
[TBL] [Abstract][Full Text] [Related]
17. Prenatal eradication of Hb Bart's hydrops fetalis.
Tongsong T; Wanapirak C; Sirivatanapa P; Sa-nguansermsri T; Sirichotiyakul S; Piyamongkol W; Chanprapaph P; Steger HF; Sekararithi R; Tuggapichitti A
J Reprod Med; 2001 Jan; 46(1):18-22. PubMed ID: 11209626
[TBL] [Abstract][Full Text] [Related]
18. Preliminary data on preimplantation genetic diagnosis for hemoglobinopathies in Turkey.
Zeren F; Genç A; Cürük MA
Hemoglobin; 2007; 31(2):273-7. PubMed ID: 17486511
[TBL] [Abstract][Full Text] [Related]
19. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates.
Al Hosani H; Salah M; Osman HM; Farag HM; Anvery SM
East Mediterr Health J; 2005 May; 11(3):300-7. PubMed ID: 16602448
[TBL] [Abstract][Full Text] [Related]
20. [Large-scale population-based genetic screening and prenatal diagnosis for thalassemias in Zhuhai City of Guangdong Province].
Zhou YQ; Shang X; Yin BM; Xiong F; Xiao QZ; Zhou WJ; Zhang YL; Xu XM
Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):90-5. PubMed ID: 22455738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
